Selected article for: "cell line and human protein"

Author: Williams, Thomas L.; Colzani, Maria T.; Macrae, Robyn G. C.; Robinson, Emma L.; Bloor, Stuart; Greenwood, Edward J. D.; Zhan, Jun Ru; Strachan, Gregory; Kuc, Rhoda E.; Nyimanu, Duuamene; Maguire, Janet J.; Lehner, Paul J.; Sinha, Sanjay; Davenport, Anthony P.
Title: Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection
  • Cord-id: gu8fdppu
  • Document date: 2021_7_29
  • ID: gu8fdppu
    Snippet: Patients with cardiovascular comorbidities are more susceptible to severe infection with SARS-CoV-2, known to directly cause pathological damage to cardiovascular tissue. We outline a screening platform using human embryonic stem cell-derived cardiomyocytes, confirmed to express the protein machinery critical for SARS-CoV-2 infection, and a SARS-CoV-2 spike-pseudotyped virus system. The method has allowed us to identify benztropine and DX600 as novel inhibitors of SARS-CoV-2 infection in a clini
    Document: Patients with cardiovascular comorbidities are more susceptible to severe infection with SARS-CoV-2, known to directly cause pathological damage to cardiovascular tissue. We outline a screening platform using human embryonic stem cell-derived cardiomyocytes, confirmed to express the protein machinery critical for SARS-CoV-2 infection, and a SARS-CoV-2 spike-pseudotyped virus system. The method has allowed us to identify benztropine and DX600 as novel inhibitors of SARS-CoV-2 infection in a clinically relevant stem cell-derived cardiomyocyte line. Discovery of new medicines will be critical for protecting the heart in patients with SARS-CoV-2, and for individuals where vaccination is contraindicated.

    Search related documents:
    Co phrase search for related documents
    • accession number and acute respiratory syndrome coronavirus: 1, 2, 3
    • accession number and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
    • accessory protein and acute respiratory distress syndrome: 1, 2, 3
    • accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory protein and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action different mechanism and acute damage: 1
    • action different mechanism and acute respiratory distress syndrome: 1
    • action different mechanism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • action different mechanism and acute respiratory syndrome coronavirus: 1, 2
    • action different mechanism and acute sars cov respiratory syndrome coronavirus: 1, 2
    • actual protein and acute respiratory syndrome: 1
    • actual protein and acute respiratory syndrome coronavirus: 1
    • acute damage and additional evidence: 1, 2
    • acute respiratory distress syndrome and additional evidence: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome and low exposure: 1, 2, 3
    • acute respiratory syndrome and additional evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low exposure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and additional evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20